Response to ‘Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?’ by Moiseev et al-Reference-Cited by-同舟云学术

Response to ‘Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?’ by Moiseev et al

Published:2020-04-28 Issue:2 Volume:80 Page:e20-e20
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Spinelli Francesca Romana^ORCID,Ceccarelli Fulvia^ORCID,Di Franco Manuela,Conti Fabrizio

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference10 articles.

1. Moiseev S , Avdeev S , Brovko M . Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)? Ann Rheum Dis 2021;80:e19. doi:10.1136/annrheumdis-2020-217570

2. To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic

3. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort

4. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection;Molina;Med Mal Infect,2020

5. Chen J , Liu D , Liu L , et al . A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19). J Zhejiang Univ 2020;6.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signal amplification by reversible exchange for COVID-19 antiviral drug candidates;Scientific Reports;2020-08-31

2. Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?;Annals of the Rheumatic Diseases;2020-05-18